Association of Atrial Fibrillation Clinical Phenotypes with Treatment Patterns and Outcomes: A Multicenter Registry Study.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 29128866)

Published in JAMA Cardiol on November 12, 2017

Authors

Taku Inohara1, Peter Shrader1, Karen Pieper1, Rosalia G Blanco1, Laine Thomas1,2, Daniel E Singer3,4, James V Freeman5, Larry A Allen6, Gregg C Fonarow7, Bernard Gersh8, Michael D Ezekowitz9, Peter R Kowey9, James A Reiffel10, Gerald V Naccarelli11, Paul S Chan12, Benjamin A Steinberg13, Eric D Peterson1, Jonathan P Piccini1

Author Affiliations

1: Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
2: Section Editor.
3: Harvard Medical School, Boston, Massachusetts.
4: Massachusetts General Hospital, Boston.
5: Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.
6: University of Colorado, Denver.
7: Department of Medicine, University of California, Los Angeles.
8: Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota.
9: Lankenau Institute for Medical Research, Wynnewood, Philadelphia, Pennsylvania.
10: College of Physicians and Surgeons, Columbia University, New York, New York.
11: School of Medicine, Penn State University, Hershey, Pennsylvania.
12: Department of Cardiovascular Research, St. Luke's Mid America Heart Institute, Kansas City, Missouri.
13: University of Utah, Salt Lake City.

Articles by these authors

Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients With Heart Failure: The Better Effectiveness After Transition-Heart Failure (BEAT-HF) Randomized Clinical Trial. JAMA Intern Med (2016) 1.77

Using age- and sex-specific risk thresholds to guide statin therapy: one size may not fit all. J Am Coll Cardiol (2015) 1.53

Normal coronary rates for elective angiography in the Veterans Affairs Healthcare System: insights from the VA CART program (veterans affairs clinical assessment reporting and tracking). J Am Coll Cardiol (2013) 1.52

The Impact of Bleeding Avoidance Strategies on Hospital-Level Variation in Bleeding Rates Following Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry CathPCI Registry. JACC Cardiovasc Interv (2016) 1.37

Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation). J Am Coll Cardiol (2013) 1.20

Excess costs associated with complications and prolonged length of stay after congenital heart surgery. Ann Thorac Surg (2014) 1.03

Validated, electronic health record deployable prediction models for assessing patient risk of 30-day rehospitalization and mortality in older heart failure patients. JACC Heart Fail (2013) 0.99

Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry. JAMA Neurol (2015) 0.91

Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF. J Am Coll Cardiol (2016) 0.84

Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial. Heart Rhythm (2014) 0.80

Association Between Hospital Process Composite Performance and Patient Outcomes After In-Hospital Cardiac Arrest Care. JAMA Cardiol (2016) 0.79

Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary intervention. J Am Coll Cardiol (2014) 0.77

Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease. Am J Cardiol (2014) 0.77

Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry. JAMA Cardiol (2016) 0.76

Open Access Platforms for Sharing Clinical Trial Data-Reply. JAMA (2016) 0.75

Temporal Changes in the Association Between Modifiable Risk Factors and Coronary Heart Disease Incidence. JAMA (2016) 0.75

Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry. Clin Cardiol (2015) 0.75

Depression Status Is Associated with Functional Decline Over 1-Year Following Acute Stroke. J Stroke Cerebrovasc Dis (2017) 0.75

Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation. JAMA (2017) 0.75

Association of Neighborhood Demographics With Out-of-Hospital Cardiac Arrest Treatment and Outcomes: Where You Live May Matter. JAMA Cardiol (2017) 0.75

Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial). Am J Cardiol (2017) 0.75

Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation. Am J Med (2016) 0.75

Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation Trial). Am J Cardiol (2017) 0.75